Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
The best clinical paper on multiple sclerosis in 2012.
Alternative data sources for estimating multiple sclerosis prevalence.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review.
[Biomarkers in multiple sclerosis (a review and experimental data)].
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Association Between Urinary Symptoms and Urinary Tract Infection in Patients With Multiple Sclerosis.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Introduction: occupational therapy practice and research with persons with multiple sclerosis.
Vitamin D as a protective factor in multiple sclerosis.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Trigeminal neuralgia: a condition to be better understood.
Autoantibodies in pre-clinical autoimmune disease.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Vitamin D in autoimmune liver disease.
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
418
419
420
421
422
423
424
425
426
…
next ›
last »